Home/Filings/4/0001140361-09-024087
4//SEC Filing

Bissinger Ron 4

Accession 0001140361-09-024087

CIK 0000830736other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 5:17 PM ET

Size

15.4 KB

Accession

0001140361-09-024087

Insider Transaction Report

Form 4
Period: 2009-10-28
Bissinger Ron
DirectorCEO & COO
Transactions
  • Disposition to Issuer

    Common Stock

    2009-10-28180,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28$0.62/sh100,000$62,0000 total
    Exercise: $0.88Exp: 2019-09-01Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28200,0000 total
    Exercise: $1.53Exp: 2016-04-09Common Stock (200,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28$0.60/sh45,000$27,0000 total
    Exercise: $0.90Exp: 2017-02-13Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28$0.52/sh100,000$52,0000 total
    Exercise: $0.98Exp: 2018-06-16Common Stock (100,000 underlying)
Footnotes (5)
  • [F1]Disposed of pursuant to a merger agreement between the Issuer and Cell Biosciences, Inc. in exchange for a cash payment of $1.50 per share on the effective date of the merger.
  • [F2]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled on the effective date of the merger.
  • [F3]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $27,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
  • [F4]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $52,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
  • [F5]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $62,000, representing the difference between the exercise price of the option and the merger price ($1.50 per share).

Documents

1 file

Issuer

ALPHA INNOTECH CORP

CIK 0000830736

Entity typeother

Related Parties

1
  • filerCIK 0001359029

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:17 PM ET
Size
15.4 KB